Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

XNCR

Xencor Inc

Feb 06 • 04:00PM ET

11.61

+0.79 7.30 %

Healthcare • Biotechnology • USA • NASD

Peers: REGN VRTX BIIB ALNY INCY BLUE SGMO KYNB PGEN ADAP

| Held by: IJR VTI IWM XBI VB VXF IJS SPSM VBK IWN

Index	RUT	P/E	-	EPS (ttm)	-1.78	Insider Own	6.09%	Shs Outstand	71.34M	Perf Week	-3.97%
Market Cap	829.08M	Forward P/E	-	EPS next Y	-2.75	Insider Trans	-4.14%	Shs Float	67.06M	Perf Month	-22.34%
Enterprise Value	560.45M	PEG	-	EPS next Q	-0.60	Inst Own	111.91%	Short Float	15.37%	Perf Quarter	-19.21%
Income	-130.82M	P/S	5.52	EPS this Y	48.71%	Inst Trans	-6.09%	Short Ratio	13.77	Perf Half Y	58.61%
Sales	150.13M	P/B	1.32	EPS next Y	-49.67%	ROA	-14.00%	Short Interest	10.31M	Perf YTD	-24.17%
Book/sh	8.76	P/C	1.76	EPS next 5Y	10.38%	ROE	-19.61%	52W High	18.69 -37.88%	Perf Year	-33.73%
Cash/sh	6.60	P/FCF	-	EPS past 3/5Y	- -	ROIC	-16.81%	52W Low	6.92 67.77%	Perf 3Y	-66.05%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-26.22% -6.75%	Gross Margin	92.71%	Volatility	6.66% 5.97%	Perf 5Y	-74.77%
Dividend TTM	-	EV/Sales	3.73	EPS Y/Y TTM	48.43%	Oper. Margin	-91.29%	ATR (14)	0.79	Perf 10Y	7.30%
Dividend Ex-Date	-	Quick Ratio	5.99	Sales Y/Y TTM	38.16%	Profit Margin	-87.14%	RSI (14)	35.86	Recom	1.21
Dividend Gr. 3/5Y	- -	Current Ratio	5.99	EPS Q/Q	88.80%	SMA20	-8.96%	Beta	0.99	Target Price	28.83
Payout	-	Debt/Eq	0.32	Sales Q/Q	18.00%	SMA50	-21.33%	Rel Volume	0.84	Prev Close	10.82
Employees	250	LT Debt/Eq	0.24	Earnings	Nov 05 AMC	SMA200	2.83%	Avg Volume	748.64K	Price	11.61
IPO	Dec 03, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	88.38% -26.86%	Trades		Volume	630,096	Change	7.30%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-24-25	Initiated	Truist	Buy
Oct-29-25	Upgrade	Barclays	Underweight → Overweight	$23
Sep-17-25	Resumed	Barclays	Underweight	$6
Sep-03-25	Downgrade	BofA Securities	Buy → Neutral	$12
Apr-21-25	Initiated	William Blair	Outperform
Dec-12-24	Initiated	Wells Fargo	Overweight	$37
Dec-02-24	Upgrade	Piper Sandler	Neutral → Overweight	$20 → $30
Apr-16-24	Reiterated	BTIG Research	Buy	$56 → $38
Feb-28-24	Downgrade	Piper Sandler	Overweight → Neutral	$37 → $24
May-19-23	Initiated	BofA Securities	Buy	$42
Dec-06-22	Initiated	Cowen	Outperform
Oct-13-22	Upgrade	Raymond James	Outperform → Strong Buy	$58
Sep-21-22	Initiated	JP Morgan	Overweight	$37
Jul-06-22	Resumed	Canaccord Genuity	Buy	$50
Feb-11-22	Initiated	BMO Capital Markets	Outperform	$54
Jan-21-22	Initiated	SMBC Nikko	Outperform	$60
Dec-15-21	Initiated	H.C. Wainwright	Buy	$61
Oct-15-21	Resumed	BTIG Research	Buy	$56
Feb-24-21	Upgrade	Raymond James	Mkt Perform → Outperform	$58
Mar-04-20	Initiated	Barclays	Underweight	$28

Show Previous Ratings

Jan-30-26 12:24AM	Xencor (XNCR): BofA Bullish on US Biopharmaceuticals Coverage (Insider Monkey)
Jan-08-26 08:01AM	Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones (Business Wire) -5.08%
Dec-09-25 07:00AM	Xencor Announces Extension of U.S. Patent Term on Certain Xtend Antibodies (Business Wire)
Nov-10-25 04:01PM	Xencor to Participate at Upcoming Investor Conferences (Business Wire) +8.22%
Nov-05-25 05:35PM	Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:47PM	Loading…
04:47PM	Xencor: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Xencor Reports Third Quarter 2025 Financial Results (Business Wire)
06:08AM	Beaten Down by 35%-Plus: Analysts Say These 2 Oversold Stocks Are Poised to Turn the Corner (TipRanks)
Nov-04-25 07:10AM	Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Oct-24-25 12:30PM	Xencor Presents Initial Data for XmAb819, a First-in-class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Clear Cell Renal Cell Carcinoma (Business Wire) +7.05%
Oct-21-25 08:01AM	Xencor to Host Webcast and Conference Call to Discuss Initial Results from the Ongoing Phase 1 Dose-Escalation Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma (Business Wire)
Oct-17-25 09:50AM	Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation (PR Newswire)
Oct-16-25 01:40PM	Xencor Stock Earns Relative Strength Rating Upgrade (Investor's Business Daily) +6.03%
Oct-14-25 12:45PM	Xencor Announces Presentation of Initial Phase 1 Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (Business Wire) -10.96%
Oct-02-25 02:39PM	How to make money from tax-loss selling between now and the end of the year (MarketWatch)
10:05AM	Loading…
Sep-18-25 10:05AM	Strength Seen in Xencor (XNCR): Can Its 7.3% Jump Turn into More Strength? (Zacks) +8.43%
Sep-08-25 12:30AM	RBC Cuts Xencor (XNCR) Price Target but Keeps Outperform Rating (Insider Monkey)
Aug-27-25 04:01PM	Xencor to Participate at Upcoming Investor Conferences (Business Wire)
Aug-08-25 09:05AM	Xencor price target lowered to $26 from $31 at Wedbush (TipRanks)
Aug-06-25 05:35PM	Xencor (XNCR) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.79%
04:36PM	Xencor: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Xencor Reports Second Quarter 2025 Financial Results (Business Wire)
Jul-31-25 04:01PM	Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors (Business Wire)
07:15AM	Aurinia Pharmaceuticals (AUPH) Q2 Earnings Miss Estimates (Zacks)
May-07-25 05:30PM	Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.61% +10.08%
04:26PM	Xencor: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Xencor Reports First Quarter 2025 Financial Results (Business Wire)
May-01-25 10:01AM	Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-29-25 04:01PM	Xencor Announces Positive Interim Results From First-in-Human Healthy Volunteer Study of XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, in Development for Treatment of Inflammatory Bowel Disease (Business Wire)
Apr-11-25 10:15AM	Xencor, Inc.: No Major Near Term Catalysts (Seeking Alpha) +7.83%
12:00PM	Loading…
Apr-10-25 12:00PM	Xencor (XNCR) Upgraded to Buy: Here's Why (Zacks) -10.10%
Mar-13-25 04:01PM	Xencor Appoints Todd Simpson to Board of Directors (Business Wire)
Feb-27-25 09:15AM	Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:15AM	Xencor: Q4 Earnings Snapshot (Associated Press Finance)
08:01AM	Xencor Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Feb-06-25 09:35AM	Xencor (XNCR) Loses -25.22% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jan-21-25 09:35AM	Down -21.69% in 4 Weeks, Here's Why Xencor (XNCR) Looks Ripe for a Turnaround (Zacks) +6.29%
Jan-20-25 09:35AM	After Plunging -20.27% in 4 Weeks, Here's Why the Trend Might Reverse for Xencor (XNCR) (Zacks)
Jan-15-25 09:35AM	Here's Why Xencor (XNCR) is Poised for a Turnaround After Losing -23.68% in 4 Weeks (Zacks)
Jan-14-25 12:00PM	Xencor (XNCR) Upgraded to Strong Buy: Here's What You Should Know (Zacks) -5.68%
Dec-12-24 12:00PM	All You Need to Know About Xencor (XNCR) Rating Upgrade to Buy (Zacks)
Dec-04-24 09:55AM	Wall Street Analysts Think Xencor (XNCR) Could Surge 31.58%: Read This Before Placing a Bet (Zacks)
Nov-26-24 04:01PM	Xencor to Participate at Upcoming Investor Conferences (Business Wire)
Nov-18-24 09:55AM	Wall Street Analysts Believe Xencor (XNCR) Could Rally 53.53%: Here's is How to Trade (Zacks)
Nov-14-24 09:55AM	Xencor (XNCR)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
Nov-06-24 05:15PM	Xencor (XNCR) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +5.39%
04:11PM	Xencor: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Xencor Reports Third Quarter 2024 Financial Results (Business Wire)
Nov-04-24 07:00AM	Xencor Doses First Subject in Phase 1/2 Study of XmAb942 in Development for Patients with Inflammatory Bowel Disease (Business Wire)
Nov-01-24 09:55AM	Does Xencor (XNCR) Have the Potential to Rally 68.16% as Wall Street Analysts Expect? (Zacks)
Oct-29-24 10:01AM	Xencor (XNCR) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-18-24 03:05PM	State Street Corp's Strategic Reduction in Xencor Inc Holdings (GuruFocus.com)
Oct-16-24 09:55AM	Wall Street Analysts Predict a 67.2% Upside in Xencor (XNCR): Here's What You Should Know (Zacks)
Oct-10-24 08:09AM	Xencor Presents Preclinical Data on XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, to be Developed for Patients with Inflammatory Bowel Diseases (Business Wire)
Oct-04-24 08:01AM	Xencor Announces Upcoming Change to Board of Directors (Business Wire)
Sep-12-24 04:01PM	Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares (Business Wire)
04:55AM	Xencor (XNCR) Surges 10.5%: Is This an Indication of Further Gains? (Zacks)
Sep-11-24 06:31AM	Xencor Announces Pricing of $175 Million Public Offering of Common Stock (Business Wire) +10.45%
Sep-10-24 04:01PM	Xencor Announces Proposed Public Offering of Common Stock (Business Wire)
Sep-09-24 07:31AM	Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs (Business Wire) +22.93%
Sep-06-24 08:01AM	Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024 (Business Wire)
Aug-05-24 09:55PM	XNCR Stock Earnings: Xencor Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace) -7.30%
05:15PM	Xencor (XNCR) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:12PM	Xencor: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Xencor Reports Second Quarter 2024 Financial Results (Business Wire)
Jun-13-24 08:01AM	Xencor Regains CD20 x CD3 Bispecific T-Cell Engager (Business Wire)
May-10-24 01:45PM	Xencor Inc (XNCR) Q1 2024 Earnings: Misses Revenue and Earnings Estimates (GuruFocus.com)
06:20AM	Wedbush Adjusts Xencor's Price Target to $36 From $34, Keeps Outperform Rating (MT Newswires)
May-09-24 11:54PM	XNCR Stock Earnings: Xencor Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:18PM	Xencor: Q1 Earnings Snapshot (Associated Press Finance)
04:09PM	Xencor Reports First Quarter 2024 Financial Results (Business Wire)
May-06-24 10:00AM	Xencor (XNCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
May-03-24 07:01PM	Insider Sale at Xencor Inc (XNCR): EVP, Chief Development Officer Nancy Valente Sells Shares (GuruFocus.com)
May-02-24 03:31AM	Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last? (Zacks)
Apr-09-24 08:01AM	Xencor Appoints Bart Cornelissen as Chief Financial Officer (Business Wire)
Mar-08-24 05:01PM	Insider Sell: SR. VICE PRESIDENT & CFO John Kuch Sells 4,474 Shares of Xencor Inc (XNCR) (GuruFocus.com)
Mar-07-24 05:00PM	Insider Sell: President & CEO Bassil Dahiyat Sells 12,528 Shares of Xencor Inc (XNCR) (GuruFocus.com)
Feb-28-24 04:01PM	Xencor to Present at Upcoming Investor Conferences (Business Wire) -14.06%
09:35AM	Q4 2023 Xencor Inc Earnings Call (Thomson Reuters StreetEvents)
08:38AM	Xencor, Inc. (NASDAQ:XNCR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 05:20PM	Xencor (XNCR) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:39PM	Xencor Inc (XNCR) Reports Mixed Financial Results for Q4 and Full Year 2023 (GuruFocus.com)
04:26PM	Xencor: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Xencor Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-20-24 04:31PM	Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update (Business Wire)
Feb-19-24 03:37AM	Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains? (Zacks)
Feb-15-24 10:00AM	Xencor (XNCR) Earnings Expected to Grow: What to Know Ahead of Q4 Release (Zacks) +5.97%
Jan-03-24 04:01PM	Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
09:55AM	Xencor (XNCR) Soars 6.0%: Is Further Upside Left in the Stock? (Zacks)
Jan-02-24 08:01AM	Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy (Business Wire) +6.03%
Dec-30-23 05:02PM	Insider Sell: Xencor Inc President & CEO Bassil Dahiyat Sells 45,000 Shares (GuruFocus.com)
Nov-21-23 04:01PM	Xencor to Present at the Piper Sandler 35th Annual Healthcare Conference (Business Wire) -6.99%
Nov-09-23 02:19PM	Xencor, Inc. (NASDAQ:XNCR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 05:21AM	Xencor pulls back from Genentech cancer pact to cut costs, as CytomX drops ex-AbbVie ADC (FierceBiotech.com) -7.01%
Nov-07-23 04:39PM	Xencor: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Xencor Sells Portion of Royalties and Milestones from Ultomiris and Monjuvi to OMERS Life Sciences for $215 Million (Business Wire)
04:01PM	Xencor Reports Third Quarter 2023 Financial Results (Business Wire)
Nov-03-23 12:01PM	Xencor Presents Preclinical Data from Multiple XmAb Research Programs at the SITC Annual Meeting (Business Wire) +5.49%
Oct-31-23 04:01PM	Xencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023 (Business Wire)
12:00PM	Xencor (XNCR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Desjarlais John R	SR. VICE PRESIDENT & CSO	Jan 23 '26	Option Exercise	12.51	5,322	66,578	248,207	Jan 26 04:01 PM
Desjarlais John R	SR. VICE PRESIDENT & CSO	Dec 19 '25	Option Exercise	12.51	73,367	917,821	309,941	Dec 23 04:02 PM
Desjarlais John R	SR. VICE PRESIDENT & CSO	Dec 22 '25	Option Exercise	12.51	6,311	78,951	242,885	Dec 23 04:02 PM
Desjarlais John R	SR. VICE PRESIDENT & CSO	Dec 19 '25	Sale	15.72	73,367	1,153,329	236,574	Dec 23 04:02 PM
Dahiyat Bassil I	PRESIDENT & CEO	Dec 19 '25	Option Exercise	12.51	114,377	1,430,856	581,012	Dec 23 04:01 PM
Dahiyat Bassil I	PRESIDENT & CEO	Dec 22 '25	Option Exercise	12.51	10,624	132,906	477,259	Dec 23 04:01 PM
Dahiyat Bassil I	PRESIDENT & CEO	Dec 19 '25	Sale	15.71	114,377	1,796,863	466,635	Dec 23 04:01 PM
Desjarlais John R	Officer	Dec 19 '25	Proposed Sale	15.72	73,367	1,153,517		Dec 19 04:19 PM
Dahiyat Bassil I	Officer	Dec 19 '25	Proposed Sale	15.71	114,377	1,796,943		Dec 19 04:13 PM
Montgomery Alan Bruce	Director	Jun 16 '25	Sale	9.22	2,215	20,422	20,611	Jun 16 07:35 PM
GUSTAFSON KURT A	Director	Jun 16 '25	Sale	9.22	2,993	27,595	20,183	Jun 16 07:31 PM
GORMAN KEVIN CHARLES	Director	Jun 16 '25	Sale	9.22	3,173	29,255	18,905	Jun 16 07:30 PM
Feigal Ellen	Director	Jun 16 '25	Sale	9.22	2,993	27,595	19,183	Jun 16 07:26 PM
RANIERI RICHARD J	Director	Jun 16 '25	Sale	9.22	2,993	27,595	19,183	Jun 16 07:22 PM
GUSTAFSON KURT A	Director	Jun 16 '25	Proposed Sale	9.19	2,993	27,506		Jun 16 12:53 PM
Montgomery Alan Bruce	Director	Jun 16 '25	Proposed Sale	9.22	2,215	20,422		Jun 16 12:30 PM
GORMAN KEVIN CHARLES	Director	Jun 16 '25	Proposed Sale	9.22	3,173	29,255		Jun 16 12:14 PM
Feigal Ellen	Director	Jun 16 '25	Proposed Sale	9.22	2,993	27,595		Jun 16 12:07 PM
RANIERI RICHARD J	Director	Jun 16 '25	Proposed Sale	9.22	2,993	27,595		Jun 16 10:29 AM
Valente Nancy	EVP, Chief Development Officer	May 02 '25	Sale	11.03	4,616	50,914	49,169	May 06 04:40 PM
Valente Nancy	Officer	May 02 '25	Proposed Sale	11.03	4,616	50,914		May 02 03:23 PM
Cornelissen Bart Jan	SR. VICE PRESIDENT & CFO	Apr 10 '25	Sale	8.06	3,750	30,233	61,348	Apr 14 04:13 PM
Cornelissen Bart Jan	Officer	Apr 10 '25	Proposed Sale	8.06	3,750	30,233		Apr 10 03:21 PM
Valente Nancy	EVP, Chief Development Officer	Mar 10 '25	Sale	13.60	2,565	34,877	53,785	Mar 11 04:28 PM
Eckert Celia	SVP, GENERAL COUNSEL	Mar 10 '25	Sale	13.60	5,740	78,047	63,507	Mar 11 04:26 PM
Desjarlais John R	SR. VICE PRESIDENT & CSO	Mar 10 '25	Sale	13.60	9,697	131,851	236,574	Mar 11 04:25 PM
Dahiyat Bassil I	PRESIDENT & CEO	Mar 10 '25	Sale	13.60	19,716	268,080	465,419	Mar 11 04:23 PM
Eckert Celia	Officer	Mar 10 '25	Proposed Sale	13.60	5,740	78,047		Mar 10 04:26 PM
Valente Nancy	Officer	Mar 10 '25	Proposed Sale	13.60	2,565	34,877		Mar 10 04:21 PM
Desjarlais John R	Officer	Mar 10 '25	Proposed Sale	13.60	9,697	131,851		Mar 10 04:19 PM
Dahiyat Bassil I	Officer	Mar 10 '25	Proposed Sale	13.60	19,716	268,080		Mar 10 04:17 PM

Open in Screener

AWRE

Aware Inc

Feb 06 • 04:00PM ET

1.80

+0.04 2.27 %

Technology • Software - Application • USA • NASD

Peers: CSCO PANW FTNT CHKP JNPR FFIV QLYS CYBR RPD AKAM

| Held by: VTI VXF IWC DFAS DFSU DFUV DCOR DFAC

Index	-	P/E	-	EPS (ttm)	-0.26	Insider Own	45.17%	Shs Outstand	21.36M	Perf Week	-0.55%
Market Cap	38.47M	Forward P/E	-	EPS next Y	-	Insider Trans	0.40%	Shs Float	11.72M	Perf Month	-8.16%
Enterprise Value	20.01M	PEG	-	EPS next Q	-	Inst Own	18.70%	Short Float	0.27%	Perf Quarter	-18.74%
Income	-5.61M	P/S	2.21	EPS this Y	-	Inst Trans	-3.85%	Short Ratio	1.06	Perf Half Y	-16.28%
Sales	17.43M	P/B	1.41	EPS next Y	-	ROA	-13.36%	Short Interest	0.03M	Perf YTD	-2.70%
Book/sh	1.28	P/C	1.71	EPS next 5Y	-	ROE	-18.98%	52W High	2.95 -38.98%	Perf Year	5.88%
Cash/sh	1.05	P/FCF	-	EPS past 3/5Y	8.16% 11.57%	ROIC	-18.33%	52W Low	1.37 31.39%	Perf 3Y	-1.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	1.05% 7.34%	Gross Margin	91.04%	Volatility	5.90% 4.94%	Perf 5Y	-54.55%
Dividend TTM	-	EV/Sales	1.15	EPS Y/Y TTM	25.65%	Oper. Margin	-37.76%	ATR (14)	0.10	Perf 10Y	-40.20%
Dividend Ex-Date	Jul 25, 2014	Quick Ratio	3.36	Sales Y/Y TTM	2.73%	Profit Margin	-32.20%	RSI (14)	38.90	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.36	EPS Q/Q	9.80%	SMA20	-3.41%	Beta	0.82	Target Price	3.00
Payout	-	Debt/Eq	0.15	Sales Q/Q	33.26%	SMA50	-9.48%	Rel Volume	0.74	Prev Close	1.76
Employees	64	LT Debt/Eq	0.12	Earnings	Oct 29 AMC	SMA200	-14.86%	Avg Volume	29.47K	Price	1.80
IPO	Aug 09, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	21,786	Change	2.27%

Date	Action	Analyst	Rating Change	Price Target Change
May-09-08	Downgrade	Merriman Curhan Ford	Buy → Neutral
May-01-07	Initiated	Merriman Curhan Ford	Buy
Mar-23-07	Initiated	MDB Capital Group	Buy	$7.50

Nov-07-25 02:59AM	The Zacks Analyst Blog Morgan Stanley, Union Pacific, The Southern and Aware (Zacks) +7.86%
Nov-06-25 04:28PM	Top Stock Reports for Morgan Stanley, Union Pacific & Southern Company (Zacks)
Nov-04-25 12:53PM	Aware Stock Down Post Q3 Earnings Despite Strong Revenue Growth (Zacks)
Oct-30-25 04:09PM	Aware Inc (AWRE) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Expenses (GuruFocus.com) -5.95% -6.75%
Oct-29-25 04:10PM	Aware: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Loading…
04:00PM	Aware Reports Third Quarter and Nine-Month 2025 Financial Results (GlobeNewswire)
Oct-15-25 08:30AM	Aware Sets Third Quarter 2025 Webcast for Wednesday, October 29, 2025, at 5:00 p.m. Eastern Time (GlobeNewswire)
Oct-14-25 08:30AM	Aware Among the First to Earn FIDO Alliance Certification for Secure Identity Ahead of Authenticate 2025 (GlobeNewswire)
Sep-10-25 08:30AM	Aware Launches New Intelligent Liveness Solution (GlobeNewswire)
Aug-04-25 12:29PM	Aware Stock Dips Post Q2 Earnings Despite a Strong Biometric Pipeline (Zacks)
Jul-31-25 03:35AM	Aware Inc (AWRE) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... (GuruFocus.com) -10.17%
Jul-30-25 04:23PM	Aware: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Aware Reports Second Quarter and Six-Month 2025 Financial Results (GlobeNewswire)
Jul-16-25 08:30AM	Aware Sets Second Quarter 2025 Webcast for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time (GlobeNewswire)
Jul-01-25 11:14AM	AWRE and WIN Reality Partner to Deliver Automated AI Swing Analysis for Baseball and Softball (Business Wire)
08:30AM	Loading…
Jun-16-25 08:30AM	Aware Named Luminary in Prism Project Report as Organization Rolls Out New Platform Enhancements (GlobeNewswire)
Jun-03-25 08:30AM	Aware Achieves Best-in-Class Performance in DHS RIVTD Testing for Passive Liveness Detection (GlobeNewswire)
May-29-25 06:11AM	The Zacks Analyst Blog Highlights Alphabet, Bank of America, Roche, Village Super Market and Aware (Zacks)
May-28-25 04:54PM	Top Analyst Reports for Alphabet, Bank of America & Roche (Zacks)
May-19-25 09:01AM	Aware Taps Proven Cybersecurity Leader Lona Therrien to Boost Brand as Chief Marketing Officer (GlobeNewswire)
May-05-25 12:14PM	AWRE Stock Declines Post-Q1 Earnings Amid Lower Revenue and Losses (Zacks)
May-01-25 03:19AM	Aware Inc (AWRE) Q1 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline (GuruFocus.com)
Apr-30-25 09:53PM	Aware, Inc. (AWRE) Q1 2025 Earnings Call Transcript (Seeking Alpha)
04:47PM	Aware: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Aware Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-23-25 09:14AM	The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Berkshire Hathaway, BK Technologies and Aware (Zacks) +6.49%
Apr-22-25 01:42PM	Q1 Earnings Season Scorecard and Analyst Reports for NVIDIA, Alphabet & Berkshire Hathaway (Zacks)
Apr-17-25 09:01AM	Aware Sets First Quarter 2025 Webcast for Wednesday, April 30, 2025, at 5:00 p.m. Eastern Time (GlobeNewswire) +5.86%
Apr-02-25 09:01AM	Aware Elevates Gary Evee as Chairman of the Board of Directors (GlobeNewswire)
Mar-28-25 10:39AM	Is Aware, Inc. (AWRE) the Cheapest Stock Insiders Are Buying In March? (Insider Monkey)
09:01AM	Loading…
Mar-10-25 09:01AM	Aware Deepens Executive Bench with Appointment of Brian Krause as Chief Revenue Officer (GlobeNewswire)
Mar-06-25 07:30AM	Q4 2024 Aware Inc Earnings Call (Thomson Reuters StreetEvents) -5.30%
02:12AM	Aware Inc (AWRE) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... (GuruFocus.com)
Mar-05-25 04:19PM	Aware: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Aware Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-19-25 04:01PM	Aware Sets Fourth Quarter and Full Year 2024 Webcast for Wednesday, March 5, 2025, at 5:00 p.m. Eastern Time (GlobeNewswire)
Feb-17-25 10:28AM	Rogue Funds Sold Aware (AWRE) Amid Performance Worries and For Tax Purposes (Insider Monkey)
Feb-04-25 04:00PM	Aware Appoints Seasoned Security Executive Ajay Amlani as CEO to Lead Next Phase of Growth and Innovation (GlobeNewswire)
Jan-03-25 07:39AM	Aware (AWRE): Growth Concerns Amid Cost-Cutting Efforts and Market Challenges (Insider Monkey)
Jan-02-25 09:00AM	Aware Announces Interim Chief Executive Officer (GlobeNewswire) -14.36%
Oct-31-24 03:00PM	Aware Inc (AWRE) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges with Strategic ... (GuruFocus.com) -21.26%
Oct-30-24 04:59PM	Aware: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Aware Reports Third Quarter and Nine Month 2024 Financial Results (GlobeNewswire)
Oct-22-24 10:01AM	AwareID Plug-In for WordPress Makes Biometric Authentication Available on WordPress Marketplace (GlobeNewswire)
Oct-17-24 04:05PM	Aware Sets Third Quarter 2024 Webcast for Wednesday, October 30, 2024, at 5:00 p.m. Eastern Time (GlobeNewswire)
Oct-15-24 03:01PM	New Consumer Report from Aware Reveals Widespread Trust in Biometrics (GlobeNewswire)
Oct-09-24 05:58PM	Aware Inc (AWRE) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Moves (GuruFocus.com)
Oct-02-24 11:06AM	Aware, Inc. (AWRE): A Bull Case Theory (Insider Monkey)
Aug-12-24 12:35PM	Aware (AWRE) Q2 Earnings & Revenues Improve Y/Y, Gross Margin Up (Zacks)
Aug-08-24 04:11PM	Aware: Q2 Earnings Snapshot (Associated Press Finance) +26.89%
04:00PM	Aware Reports Second Quarter and Six Month 2024 Financial Results (GlobeNewswire)
Jul-30-24 07:00AM	The Top 7 Under-$10 Stocks to Buy Now: Summer 2024 (InvestorPlace)
Jul-25-24 04:05PM	Aware Sets Second Quarter 2024 Webcast for Thursday, August 8, 2024, at 5:00 p.m. Eastern Time (GlobeNewswire)
May-30-24 09:00AM	Aware's Newly Appointed Chief Product Officer to Lead Biometric Deepfake Discussions at Identity Week Europe 2024 (GlobeNewswire)
May-07-24 06:30AM	3 Under-$5 Penny Stocks That Could Make You Millions (InvestorPlace) +7.65%
May-06-24 10:00AM	Aware, Inc. (NASDAQ:AWRE) Q1 2024 Earnings Call Transcript (Insider Monkey) +7.10%
01:01AM	Aware Inc (AWRE) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ... (GuruFocus.com)
May-02-24 09:54PM	AWRE Stock Earnings: Aware Reported Results for Q1 2024 (InvestorPlace) -11.59%
04:17PM	Aware: Q1 Earnings Snapshot (Associated Press Finance)
04:06PM	Aware Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-18-24 04:05PM	Aware Sets First Quarter 2024 Webcast for Thursday, May 2, 2024 at 5:00 p.m. Eastern Time (GlobeNewswire)
Mar-13-24 09:32AM	Get in Quick! 7 AI Penny Stocks That Are About to Pop Soon (InvestorPlace) -10.50%
09:09AM	Aware, Inc. (NASDAQ:AWRE) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-12-24 04:24PM	Aware: Q4 Earnings Snapshot (Associated Press Finance)
04:02PM	Aware Reports Fourth Quarter Financial Results (GlobeNewswire)
Feb-22-24 04:05PM	Aware Sets Fourth Quarter and Full Year 2023 Webcast for Tuesday, March 12, 2024 at 5:00 p.m. Eastern Time (GlobeNewswire)
Jan-23-24 09:00AM	Aware Adds Product Strategy Innovator to Executive Team to Further Align Biometric Platform and Vision with Market Growth (GlobeNewswire)
Jan-03-24 07:15AM	PeopleCert chooses Aware's Knomi to Prevent Proxy Testing (PR Newswire)
Dec-19-23 03:16PM	Unlocking the Future: Aware Partners with Avanza Solutions to Extend World Class Biometric Authentication Across Middle East, Asia and Africa (GlobeNewswire) +7.79%
Nov-15-23 09:05AM	Aware and Serban Group Team Up To Create Biometric Authentication Powerhouse Serving Latin American and European Markets (GlobeNewswire)
Nov-02-23 11:34AM	Aware, Inc. (NASDAQ:AWRE) Q3 2023 Earnings Call Transcript (Insider Monkey) +45.71%
Nov-01-23 07:14PM	Aware Inc (AWRE) Q3 2023 Earnings: Revenue Soars by 112% to $6.4 Million (GuruFocus.com)
04:09PM	Aware: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Aware Reports Third Quarter and Nine Month 2023 Financial Results (GlobeNewswire)
Oct-25-23 09:05AM	Aware and PeopleCert Align to Prevent Proxy Testing (GlobeNewswire)
Oct-18-23 09:00AM	Aware Sets Third Quarter 2023 Webcast for Wednesday, November 1, 2023 at 5:00 p.m. Eastern Time (GlobeNewswire) -6.06%
Oct-17-23 09:21AM	Aware Named Catalyst and Role Model in New Biometrics Digital Identity Market Report (GlobeNewswire)
Oct-11-23 09:15AM	Aware Ranks Top Performer in NIST Face Analysis Technology Evaluation (FATE) Benchmarking Test While Optimizing Demographic Parity (GlobeNewswire)
Sep-28-23 09:00AM	Aware Launches Partner Program, Empowering Both Large and Midmarket Technology Providers to Leverage Biometrics for Enhanced Revenue Streams (GlobeNewswire)
Sep-07-23 09:00AM	Aware Premiers Powerful New AwareID® Functionality and Introduces Developer Hub to Further Simplify Businesses' Adoption of Biometric Technology (GlobeNewswire)
Aug-03-23 08:02AM	Aware, Inc. (NASDAQ:AWRE) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-02-23 08:11AM	Q2 2023 Aware Inc Earnings Call (Thomson Reuters StreetEvents) -5.17%
Aug-01-23 04:29PM	Aware: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Aware Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-27-23 09:00AM	Leading Forensic Science Facility, Miami Valley Regional Crime Laboratory/Montgomery County Coroners Office, Chooses AwareABIS to Solve Cases Faster and More Accurately (GlobeNewswire) +8.61%
Jul-18-23 09:05AM	Aware Sets Second Quarter 2023 Webcast for Tuesday, August 1, 2023 at 5:00 p.m. Eastern Time (GlobeNewswire)
Jul-12-23 08:11AM	We Think Aware (NASDAQ:AWRE) Can Afford To Drive Business Growth (Simply Wall St.)
Jun-20-23 08:00AM	Brazilian Financial Institutions Can Thwart Rising Fraud Attempts with Innovative Biometric Solutions (GlobeNewswire)
Jun-15-23 07:15AM	Insider Stock Buying Reaches US$627k On Aware \ (Simply Wall St.)
Jun-07-23 11:09AM	Biometric Authentication is Critical to Solving Identity Verification Challenges of the Digital Age (GlobeNewswire)
May-30-23 09:20AM	Aware, Inc. Announces AwareID Customer, A Safer Walk, to Implement Companys Game Changing Technology to provide Women with more Secure Connections (GlobeNewswire)
May-16-23 09:00AM	Contract Management Becomes Newest Area of Business to Embrace the Power of Biometrics (GlobeNewswire)
May-15-23 09:53AM	Biometrics: The Most Powerful Weapon in the Law Enforcement Agencies Arsenal For Expedited Investigations (GlobeNewswire)
May-10-23 09:05AM	The Governments Goal to Digitize Travel Authentication is Front and Center at Border Security Expo (GlobeNewswire)
May-05-23 12:49PM	Aware, Inc.'s (NASDAQ:AWRE) Shares Not Telling The Full Story (Simply Wall St.)
May-02-23 04:11PM	Aware: Q1 Earnings Snapshot (AP Finance)
04:01PM	Aware Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-25-23 02:36PM	Awares Biometric Authentication Solutions Take Center Stage at Fintech Americas 2023 (GlobeNewswire)
Apr-20-23 09:05AM	Aware Sets First Quarter 2023 Webcast for Tuesday, May 2, 2023 at 5:00 p.m. Eastern Time (GlobeNewswire)
Mar-28-23 09:05AM	Aware brings AwareID® to AWS Marketplace (GlobeNewswire)

Aware, Inc. is a biometrics software and services company. The firm's products are used in government and commercial biometrics systems, which are capable of determining or verifying an individual's identity. It also provides interoperable, standards-compliant, field-proven biometric functionality, used to capture, verify, format, compress and decompress biometric images, as well as aggregate, analyze, process, and transport those images within biometric systems. The company was founded in 1986 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Evee Gary	Director	Jan 02 '26	Option Exercise	0.00	28,207	0	127,764	Jan 05 05:03 PM
Johnstone Brent P	Director	Jan 02 '26	Option Exercise	0.00	27,349	0	271,653	Jan 05 05:02 PM
STAFFORD JOHN S III	Director	Jan 02 '26	Option Exercise	0.00	22,316	0	5,105,200	Jan 05 05:02 PM
Faubert Peter R.	Director	Jan 02 '26	Option Exercise	0.00	23,994	0	160,419	Jan 05 05:02 PM
Connolly Brian D	Director	Jan 02 '26	Option Exercise	0.00	25,671	0	244,455	Jan 05 05:01 PM
Amlani Ajay K	President & CEO	Nov 03 '25	Buy	2.23	13,227	29,496	835,779	Nov 05 05:35 PM
Amlani Ajay K	President & CEO	Nov 04 '25	Buy	2.26	2,262	5,112	838,041	Nov 05 05:35 PM
Amlani Ajay K	President & CEO	Sep 02 '25	Buy	2.20	10,679	23,494	822,552	Sep 02 05:53 PM
Amlani Ajay K	President & CEO	Aug 29 '25	Buy	2.19	7,000	15,330	811,873	Sep 02 05:53 PM
Krause Brian J	Chief Revenue Officer	Aug 29 '25	Buy	2.20	5,000	11,000	10,000	Sep 02 05:50 PM
Connolly Brian D	Director	Jul 01 '25	Option Exercise	0.00	25,671	0	218,784	Jul 03 04:00 PM
Evee Gary	Director	Jul 01 '25	Option Exercise	0.00	23,490	0	99,557	Jul 02 05:35 PM
Johnstone Brent P	Director	Jul 01 '25	Option Exercise	0.00	27,349	0	244,304	Jul 02 05:33 PM
STAFFORD JOHN S III	Director	Jul 01 '25	Option Exercise	0.00	22,315	0	5,082,884	Jul 02 05:23 PM
Faubert Peter R.	Director	Jul 01 '25	Option Exercise	0.00	23,993	0	136,425	Jul 02 05:22 PM
Amlani Ajay K	President & CEO	Jun 12 '25	Buy	1.70	10,000	17,000	450,273	Jun 16 04:14 PM
Amlani Ajay K	President & CEO	Jun 10 '25	Buy	1.70	14,000	23,800	440,273	Jun 12 05:09 PM
Traverse David K	Chief Financial Officer	Jun 01 '25	Option Exercise	0.00	3,476	0	50,651	Jun 03 05:39 PM
Traverse David K	Chief Financial Officer	Jun 02 '25	Buy	1.65	2,500	4,125	53,151	Jun 03 05:39 PM
Krause Brian J	Chief Revenue Officer	Mar 08 '25	Buy	1.69	2,500	4,225	5,000	May 13 04:05 PM
Amlani Ajay K	President & CEO	Mar 14 '25	Buy	1.62	11,100	17,982	415,173	Mar 17 04:15 PM
STAFFORD JOHN S III	Director	Mar 12 '25	Buy	1.65	8,758	14,451	5,060,569	Mar 14 04:00 PM
Amlani Ajay K	President & CEO	Mar 10 '25	Buy	1.50	14,505	21,758	248,944	Mar 12 05:40 PM
Faubert Peter R.	Director	Mar 12 '25	Buy	1.61	20,000	32,200	112,432	Mar 12 05:23 PM
Faubert Peter R.	Director	Mar 11 '25	Buy	1.52	1,134	1,724	92,432	Mar 12 05:23 PM
Krause Brian J	Chief Revenue Officer	Mar 07 '25	Buy	1.57	2,500	3,925	2,500	Mar 11 04:00 PM
Amlani Ajay K	President & CEO	Mar 07 '25	Buy	1.50	28,950	43,425	234,439	Mar 10 04:25 PM

XNCR

Xencor Inc

AWRE

Aware Inc

Upgrade your FINVIZ experience